Case Based for January
Teaching Case: An Escalating Agitation Syndrome with Misleading Clues An 82-year-old woman with a history of chronic pain due to metastatic diffuse large B-cell lymphoma s/p radical neck and mouth dissection and G-tube placement presented to the ED with severe oral pain, nausea, worsening anxiety, and a profound sensation of “feeling toxic.” She lived alone and managed her medications independently. She reported taking multiple doses of hydrocodone/acetaminophen and diazepam over the preceding 24 hours. She was also maintained on a PRN Valium, hydrocodone and 125 mcg/hr fentanyl patch Q3 days, but instead of applying a new patch that morning, she had removed the old patch and moved it to a new location—a practice she used because she believed relocation to a location with more body fat was equivalent to replacement. She was a very low-body-weight patient, approximately 82 lbs, which heightened her sensitivity to rapid changes in opioid exposure. On arrival, her blood pressure was 179/67, with otherwise stable vitals. She remained alert and oriented but was increasingly restless and unable to remain still. Her laboratory studies—including CBC, CMP, magnesium, phosphorus, EKG CK, troponin, and TSH—were all within normal limits, and urinalysis was unremarkable. Her urine drug screen was negative for opiates and benzodiazepines, despite her reported intake of Valium and Hydrocodone. This tox panel did not test for fentanyl. Based on her symptoms and the interpretation that she may not have adequately taken her home medications, the initial working diagnosis was acute anxiety with poorly controlled pain. At 01:26 she received lorazepam 1 mg IV and morphine 2 mg IV. Shortly thereafter, she experienced a marked and abrupt deterioration: she became intensely agitated, thrashing in bed, gripping the rails, unable to sit still, and repeatedly describing the sensation of “jumping out of my skin.” Because this escalation occurred immediately…
